Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended
	Mar. 31, 2022	Mar. 31, 2021
Revenue:
Total revenue	$ 29,724	$ 41,025
Cost of sales	23,295	16,405
Gross Profit	6,429	24,620
Operating expenses:
Research and development expenses	13,990	23,070
Selling, general, and administrative expenses	14,935	20,736
Total operating expenses	28,925	43,806
Operating loss	(22,496)	(19,186)
Interest income	77	29
Interest expense	4,521	4,908
Loss on partial extinguishment of debt	3,501
Loss before income tax expense	(30,441)	(24,065)
Income tax expense	28	154
Net loss from continuing operations	(30,469)	(24,219)
(Gain) loss from discontinued operations (Note 4)	(12,537)	1,384
Net loss	(17,932)	(25,603)
Less: net loss attributable to non-controlling interests	(512)	(553)
Net loss attributable to Athenex, Inc.	(17,420)	(25,050)
Unrealized gain on investment, net of income taxes	27	16
Foreign currency translation adjustment, net of income taxes	535	277
Comprehensive loss	$ (16,858)	$ (24,757)
Net loss from continuing operations	$ (0.27)	$ (0.25)
Net loss from discontinuing operations	0.11	(0.02)
Net loss per share attributable to Athenex, Inc. common stockholders, basic and diluted (See Note 15)	$ (0.16)	$ (0.27)
Weighted-average shares used in computing net loss per share attributable to Athenex, Inc. common stockholders, basic and diluted (See Note 15)	110,504,076	93,429,935
Product Sales, Net
Revenue:
Total revenue	$ 28,950	$ 20,360
License and Other Revenue
Revenue:
Total revenue	$ 774	$ 20,665